Literature DB >> 27497235

Regulatory T cells: balancing protection versus pathology.

Nikolas Rakebrandt1, Katharina Littringer1, Nicole Joller1.   

Abstract

Foxp3+ regulatory T cells (Tregs) maintain immune tolerance, prevent autoimmunity and modulate immune responses during infection and cancer. Recent studies have revealed considerable heterogeneity and plasticity within the Treg compartment, depending on the immunological context, which may result in Tregs losing their suppressive function in inflammatory environments. We review how dysfunctional Tregs contribute to disease pathogenesis in inflammatory conditions and how inappropriate regulatory responses may hamper protective immunity in the context of infection and cancer. We also discuss how Tregs might be targeted therapeutically to re-establish a proper balance between regulatory and effector responses in autoimmunity, infections, and cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27497235     DOI: 10.4414/smw.2016.14343

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  14 in total

1.  Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.

Authors:  J Romo-Tena; S Rajme-López; L Aparicio-Vera; J Alcocer-Varela; D Gómez-Martín
Journal:  Clin Exp Immunol       Date:  2017-10-19       Impact factor: 4.330

Review 2.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

3.  DNMT1-mediated Foxp3 gene promoter hypermethylation involved in immune dysfunction caused by arsenic in human lymphocytes.

Authors:  Yemei Ma; Ying Ye; Yining Liu; Jing Chen; Yanli Cen; Wenyan Chen; Chun Yu; Qibing Zeng; Aihua Zhang; Guanghong Yang
Journal:  Toxicol Res (Camb)       Date:  2020-08-06       Impact factor: 3.524

4.  Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy.

Authors:  Dan Ou; Julien Adam; Ingrid Garberis; Pierre Blanchard; France Nguyen; Antonin Levy; Odile Casiraghi; Philippe Gorphe; Ingrid Breuskin; François Janot; Stephane Temam; Jean-Yves Scoazec; Eric Deutsch; Yungan Tao
Journal:  Oncoimmunology       Date:  2017-07-05       Impact factor: 8.110

5.  Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity.

Authors:  Denise van Uden; Thomas Koudstaal; Jennifer A C van Hulst; Madelief Vink; Menno van Nimwegen; Leon M van den Toorn; Prewesh P Chandoesing; Annemien E van den Bosch; Mirjam Kool; Rudi W Hendriks; Karin A Boomars
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

Review 6.  Immune mediators in the tumor microenvironment of prostate cancer.

Authors:  Jinlu Dai; Yi Lu; Hernan Roca; Jill M Keller; Jian Zhang; Laurie K McCauley; Evan T Keller
Journal:  Chin J Cancer       Date:  2017-03-14

7.  Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers.

Authors:  Olaf Stuve; Per Soelberg Soerensen; Thomas Leist; Gavin Giovannoni; Yann Hyvert; Doris Damian; Fernando Dangond; Ursula Boschert
Journal:  Ther Adv Neurol Disord       Date:  2019-06-18       Impact factor: 6.570

Review 8.  Regulation of Antiviral Immune Response by N 6-Methyladenosine of mRNA.

Authors:  Baoxin Zhao; Weijie Wang; Yan Zhao; Hongxiu Qiao; Zhiyun Gao; Xia Chuai
Journal:  Front Microbiol       Date:  2021-12-16       Impact factor: 5.640

9.  Meglumine acridone acetate, the ionic salt of CMA and N-methylglucamine, induces apoptosis in human PBMCs via the mitochondrial pathway.

Authors:  Marina A Plotnikova; Sergey A Klotchenko; Artem A Kiselev; Andrey N Gorshkov; Anna-Polina S Shurygina; Kirill A Vasilyev; Urszula Uciechowska-Kaczmarzyk; Sergey A Samsonov; Alexey L Kovalenko; Andrey V Vasin
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

10.  Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised.

Authors:  A Charlotte M T de Wolf; Carla A Herberts; Marcel H N Hoefnagel
Journal:  Front Med (Lausanne)       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.